
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260727T110000
DTEND;TZID=America/Halifax:20260727T121500
DTSTAMP:20260607T152706Z
CREATED:20260607T152706Z
LAST-MODIFIED:20260607T152706Z
UID:10000742-1785150000-1785154500@oncodaily.com
SUMMARY:2026 NCCN Patient Webinar: Non-Small Cell Lung Cancer
DESCRIPTION:NCCN hosts a free patient webinar for individuals experiencing Non-Small Cell Lung Cancer\, their caregivers\, and their families is scheduled for Monday\, July 27\, 2026\, from 11:00 AM to 12:15 PM EDT as a virtual event. \nThe session is designed to help participants understand the disease and its treatment options\, engage in shared decision-making with their care teams\, and learn about clinical trials\, second opinions\, and patient-caregiver resources. The agenda features an expert panel presentation followed by a dedicated Question & Answer session\, led by presenters Dawn Owen\, MD\, PhD (Professor and Consultant at Mayo Clinic Comprehensive Cancer Center)\, Anna Schwecke\, MS\, APRN\, CNP\, OCN (Nurse Practitioner and Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center)\, and Beth Zaberdac\, MSW\, LCSW\, OSW-C (Manager of Community Engagement at the Lung Cancer Research Foundation). \nRegister Now.
URL:https://oncodaily.com/event/non-small-cell-lung-cancer-516766
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-07T192805.403.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260722T080000
DTEND;TZID=America/Halifax:20260722T090000
DTSTAMP:20260607T151052Z
CREATED:20260607T151052Z
LAST-MODIFIED:20260607T151052Z
UID:10000741-1784707200-1784710800@oncodaily.com
SUMMARY:Overcoming Challenges in High-Risk HR+/HER2- Early Breast Cancer Care
DESCRIPTION:The Team Strategies for Overcoming Challenges to Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer workshop is scheduled for Wednesday\, July 22\, 2026\, from 8:00 AM to 9:00 AM Eastern Time (ET) as a virtual event\, hosted by the private host group NC in Hendersonville\, North Carolina\, United States. \nLed by faculty presenter Jame Abraham\, MD\, FACP (Enterprise Chairman\, Department of Hematology and Medical Oncology and Professor of Medicine at Cleveland Clinic)\, this multidisciplinary workshop will provide practical insights into optimizing care for patients with high-risk HR-positive/HER2-negative early breast cancer. The session is designed to meet the educational needs of oncologists\, nurse practitioners\, physician associates\, oncology nurses\, pharmacists\, and other healthcare professionals by focusing on identifying patients eligible for adjuvant CDK4/6 inhibitors\, aligning treatment decisions with NCCN Guidelines and pivotal trial data\, and personalizing therapy based on clinical and patient-specific factors. \nRegister Now.
URL:https://oncodaily.com/event/breast-cancer-516762
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2024/11/IMG_0563.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260625T080000
DTEND;TZID=America/Halifax:20260625T170000
DTSTAMP:20260607T145923Z
CREATED:20260607T145923Z
LAST-MODIFIED:20260607T145923Z
UID:10000739-1782374400-1782406800@oncodaily.com
SUMMARY:2026 NCCN Policy Summit Webinar: Innovations in Cancer Care Through the Ages
DESCRIPTION:The 2026 NCCN Policy Summit Webinar: Innovations in Cancer Care Through the Ages is scheduled for Thursday\, June 25\, 2026. \nThis event brings together key stakeholders—including patients\, providers\, payers\, advocacy organizations\, and industry—to explore how major therapeutic and treatment innovations have shaped the modern oncology landscape. The summit will focus on the importance of maintaining an innovative ecosystem\, reviewing past research successes\, identifying future clinical advancements\, and addressing the associated financial and policy implications to benefit future generations impacted by cancer. \nRegister Now.
URL:https://oncodaily.com/event/cancer-care-516750
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-07T190010.963.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260528T130000
DTEND;TZID=America/Halifax:20260528T140000
DTSTAMP:20260522T100019Z
CREATED:20260522T100019Z
LAST-MODIFIED:20260522T100019Z
UID:10000737-1779973200-1779976800@oncodaily.com
SUMMARY:NCCN Webinar - Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations
DESCRIPTION:The NCCN (National Comprehensive Cancer Network) educational webinar\, titled “Optimizing Patient Outcomes – Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations\,” is scheduled for May 28\, 2026 from 1:00 PM to 2:00 PM EDT. \nThis program addresses the rapidly evolving systemic therapy landscape of hepatocellular carcinoma (HCC)\, specifically focusing on recent efficacy data regarding immunotherapy. The session provides a nuanced approach to individualizing treatment for patients with advanced stages of liver dysfunction\, helping clinicians decide between systemic therapy and best supportive care. \nDesigned for a multidisciplinary audience of physicians\, nurses\, pharmacists\, and physician associates\, the activity covers first-line and subsequent-line systemic therapy options. \nRegistration and course access are available through the official NCCN platform.
URL:https://oncodaily.com/event/hepatocellular-carcinoma-506400
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/05/1777295437547_11zon.webp
LOCATION:
END:VEVENT
END:VCALENDAR